{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T04:05:53Z","timestamp":1750392353932,"version":"3.41.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"am","delay-in-days":350,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.hfc.2024.12.005","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T22:10:24Z","timestamp":1738275024000},"page":"227-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune Dysregulation in Ischemic Heart Disease Among Individuals with Human Immunodeficiency Virus"],"prefix":"10.1016","volume":"21","author":[{"given":"Meilynn","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Feinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.hfc.2024.12.005_bib1","doi-asserted-by":"crossref","first-page":"e2327584","DOI":"10.1001\/jamanetworkopen.2023.27584","article-title":"Aging-related comorbidity burden among women and men with or at-risk for HIV in the US, 2008-2019","volume":"6","author":"Collins","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.hfc.2024.12.005_bib2","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1161\/CIR.0000000000000695","article-title":"Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American heart association","volume":"140","author":"Feinstein","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.005_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1161\/CIRCULATIONAHA.122.057443","article-title":"Cardiovascular disease among persons living with HIV: new insights into pathogenesis and clinical manifestations in a global context","volume":"147","author":"Ntsekhe","year":"2023","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.hfc.2024.12.005_bib4","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","article-title":"Global burden of atherosclerotic cardiovascular disease in people living with HIV","volume":"138","author":"Shah","year":"2018","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.hfc.2024.12.005_bib5","doi-asserted-by":"crossref","first-page":"e025874","DOI":"10.1136\/bmjopen-2018-025874","article-title":"Risk of myocardial infarction among people living with HIV: an updated systematic review and meta-analysis","volume":"9","author":"Eyawo","year":"2019","journal-title":"BMJ Open"},{"issue":"11\u201312","key":"10.1016\/j.hfc.2024.12.005_bib6","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1089\/aid.2019.0126","article-title":"Low CD4 cell counts are associated with carotid plaque and intima-media thickness in virologically suppressed HIV-infected asians older than 50 years","volume":"35","author":"Siwamogsatham","year":"2019","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"17","key":"10.1016\/j.hfc.2024.12.005_bib7","doi-asserted-by":"crossref","first-page":"e017578","DOI":"10.1161\/JAHA.119.017578","article-title":"HIV infection and long-term residual cardiovascular risk after acute coronary syndrome","volume":"9","author":"Boccara","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.hfc.2024.12.005_bib8","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/S2352-3018(18)30295-9","article-title":"Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies","volume":"6","author":"Althoff","year":"2019","journal-title":"Lancet HIV"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.005_bib9","doi-asserted-by":"crossref","first-page":"e013744","DOI":"10.1161\/JAHA.119.013744","article-title":"Excess risk for atherosclerotic cardiovascular outcomes among US adults with HIV in the current era","volume":"9","author":"Rosenson","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.hfc.2024.12.005_bib10","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00143.2023","article-title":"Coronary artery endothelial function and aging in people with HIV and HIV-negative individuals","volume":"325","author":"Ziogos","year":"2023","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"10.1016\/j.hfc.2024.12.005_bib11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cjca.2018.11.005","article-title":"Lipid abnormalities in persons living with HIV infection","volume":"35","author":"Waters","year":"2019","journal-title":"Can J Cardiol"},{"issue":"5","key":"10.1016\/j.hfc.2024.12.005_bib12","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/cid\/ciz283","article-title":"Antiretroviral drugs associated with subclinical coronary artery disease in the Swiss human immunodeficiency virus cohort study","volume":"70","author":"Kovari","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.hfc.2024.12.005_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/v11030200","article-title":"Immune activation, inflammation, and non-AIDS Co-morbidities in HIV-infected patients under long-term ART","volume":"11","author":"Zicari","year":"2019","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.hfc.2024.12.005_bib14","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/cid\/ciac874","article-title":"Association between the development of subclinical cardiovascular disease and human immunodeficiency virus (HIV) reservoir markers in people with HIV on suppressive antiretroviral therapy","volume":"76","author":"Turcotte","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.hfc.2024.12.005_bib15","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1093\/cid\/ciaa1014","article-title":"Atherosclerotic cardiovascular events in patients infected with human immunodeficiency virus and hepatitis C virus","volume":"72","author":"Tan","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.hfc.2024.12.005_bib16","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1161\/ATVBAHA.120.315786","article-title":"Anticytomegalovirus CD4(+) T cells are associated with subclinical atherosclerosis in persons with HIV","volume":"41","author":"Wanjalla","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.hfc.2024.12.005_bib17","doi-asserted-by":"crossref","first-page":"664371","DOI":"10.3389\/fimmu.2021.664371","article-title":"Upregulated IL-32 expression and reduced gut short chain fatty acid caproic acid in people living with HIV with subclinical atherosclerosis","volume":"12","author":"El-Far","year":"2021","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.hfc.2024.12.005_bib18","doi-asserted-by":"crossref","first-page":"ofab109","DOI":"10.1093\/ofid\/ofab109","article-title":"Circulating \u03b2-d-Glucan as a marker of subclinical coronary plaque in antiretroviral therapy-treated people with human immunodeficiency virus","volume":"8","author":"Isnard","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.hfc.2024.12.005_bib19","article-title":"Plasmatic HIV-1 soluble gp120 is associated with correlates of immune dysfunction and inflammation in ART-treated individuals with undetectable viremia","author":"Benlarbi","year":"2023","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.hfc.2024.12.005_bib20","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.cjca.2018.11.029","article-title":"Coronary artery disease manifestations in HIV: what, how, and why","volume":"35","author":"Sinha","year":"2019","journal-title":"Can J Cardiol"},{"issue":"18","key":"10.1016\/j.hfc.2024.12.005_bib21","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/j.jacc.2016.07.771","article-title":"HIV-related myocardial vulnerability to infarction and coronary artery disease","volume":"68","author":"Feinstein","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2024.12.005_bib22","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s12350-016-0689-7","article-title":"Differences by HIV serostatus in coronary artery disease severity and likelihood of percutaneous coronary intervention following stress testing","volume":"25","author":"Feinstein","year":"2018","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.005_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/25787489.2021.1911502","article-title":"Clinical and angiographical features of first episode of acute coronary syndrome in patients with human immunodeficiency virus infection","volume":"22","author":"Uccello","year":"2021","journal-title":"HIV Res Clin Pract"},{"issue":"19","key":"10.1016\/j.hfc.2024.12.005_bib24","doi-asserted-by":"crossref","first-page":"e019291","DOI":"10.1161\/JAHA.120.019291","article-title":"Coronary artery calcification and plaque characteristics in people living with HIV: a systematic review and meta-analysis","volume":"10","author":"Soares","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"12","key":"10.1016\/j.hfc.2024.12.005_bib25","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1097\/QAD.0000000000002297","article-title":"Coronary atherosclerosis characteristics in HIV-infected patients on long-term antiretroviral therapy: insights from coronary computed tomography-angiography","volume":"33","author":"Senoner","year":"2019","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.005_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12916-019-1385-7","article-title":"Mortality following myocardial infarction among HIV-infected persons: the center for AIDS research network of integrated clinical systems (CNICS)","volume":"17","author":"Feinstein","year":"2019","journal-title":"BMC Med"},{"issue":"2","key":"10.1016\/j.hfc.2024.12.005_bib27","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/QAI.0000000000002534","article-title":"Brief report: differences in types of myocardial infarctions among people aging with HIV","volume":"86","author":"Crane","year":"2021","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"12","key":"10.1016\/j.hfc.2024.12.005_bib28","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1097\/QAD.0000000000002991","article-title":"HIV serostatus and incident coronary artery stenosis in men with a baseline zero coronary artery calcium","volume":"35","author":"Sarkar","year":"2021","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.hfc.2024.12.005_bib29","article-title":"Subclinical atherosclerosis imaging in people living with HIV","volume":"8","author":"Schoepf","year":"2019","journal-title":"J\u00a0Clin Med"},{"issue":"3","key":"10.1016\/j.hfc.2024.12.005_bib30","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/1358863X20978702","article-title":"Imaging modalities for cardiovascular phenotyping in asymptomatic people living with HIV","volume":"26","author":"Bonou","year":"2021","journal-title":"Vasc Med"},{"issue":"3","key":"10.1016\/j.hfc.2024.12.005_bib31","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1148\/radiol.2021203297","article-title":"Prevalence and characterization of subclinical coronary atherosclerotic plaque with CT among individuals with HIV: results from the Canadian HIV and aging cohort study","volume":"299","author":"Boldeanu","year":"2021","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.005_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcct.2021.06.003","article-title":"Chronic inflammatory diseases and coronary heart disease: insights from cardiovascular CT","volume":"16","author":"Patel","year":"2022","journal-title":"J\u00a0Cardiovasc Comput Tomogr"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.005_bib33","doi-asserted-by":"crossref","first-page":"e014018","DOI":"10.1161\/JAHA.119.014018","article-title":"Coronary microvascular dysfunction in HIV: a review","volume":"9","author":"Rethy","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.hfc.2024.12.005_bib34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fcvm.2018.00185","article-title":"HIV proteins and endothelial dysfunction: implications in cardiovascular disease","volume":"5","author":"Anand","year":"2018","journal-title":"Front Cardiovasc Med"},{"issue":"22","key":"10.1016\/j.hfc.2024.12.005_bib35","doi-asserted-by":"crossref","first-page":"e029541","DOI":"10.1161\/JAHA.123.029541","article-title":"Coronary microcirculatory dysfunction in people with HIV and its association with antiretroviral therapy","volume":"12","author":"Huck","year":"2023","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.hfc.2024.12.005_bib36","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/hiv.13484","article-title":"The role of HIV as a risk modifier for coronary endothelial function in young adults","volume":"24","author":"Abd-Elmoniem","year":"2023","journal-title":"HIV Med"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.005_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/QAI.0000000000003162","article-title":"The relationship between impaired coronary endothelial function and systemic markers of inflammation in people living with HIV","volume":"93","author":"Bagchi","year":"2023","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"10","key":"10.1016\/j.hfc.2024.12.005_bib38","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/hiv.13166","article-title":"Cardiac adiposity as a modulator of cardiovascular disease in HIV","volume":"22","author":"Bonou","year":"2021","journal-title":"HIV Med"},{"issue":"9","key":"10.1016\/j.hfc.2024.12.005_bib39","doi-asserted-by":"crossref","first-page":"e32980","DOI":"10.1097\/MD.0000000000032980","article-title":"Epicardial fat density, coronary artery disease and inflammation in people living with HIV","volume":"102","author":"Sadouni","year":"2023","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.hfc.2024.12.005_bib40","doi-asserted-by":"crossref","first-page":"ofad328","DOI":"10.1093\/ofid\/ofad328","article-title":"Association of soluble markers of inflammation with peri-coronary artery inflammation in people with and without HIV infection and without cardiovascular disease","volume":"10","author":"Freeman","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.hfc.2024.12.005_bib41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijcard.2016.05.027","article-title":"Heart failure in patients with human immunodeficiency virus infection: epidemiology and management disparities","volume":"218","author":"Al-Kindi","year":"2016","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2024.12.005_bib42","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cjca.2018.10.009","article-title":"Cardiomyopathy and heart failure in patients with HIV infection","volume":"35","author":"Savvoulidis","year":"2019","journal-title":"Can J Cardiol"},{"issue":"21","key":"10.1016\/j.hfc.2024.12.005_bib43","doi-asserted-by":"crossref","first-page":"e009985","DOI":"10.1161\/JAHA.118.009985","article-title":"Adjudicated heart failure in HIV-infected and uninfected men and women","volume":"7","author":"Feinstein","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.hfc.2024.12.005_bib44","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/jamacardio.2017.0264","article-title":"Association between HIV infection and the risk of heart failure with reduced ejection fraction and preserved ejection fraction in the antiretroviral therapy era: results from the veterans aging cohort study","volume":"2","author":"Freiberg","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.005_bib45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jacc.2016.11.013","article-title":"HIV infection and heart failure outcomes in women","volume":"69","author":"Janjua","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.hfc.2024.12.005_bib46","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.jcmg.2021.01.042","article-title":"Myocardial fibrosis and inflammation by CMR predict cardiovascular outcome in people living with HIV","volume":"14","author":"de Leuw","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.hfc.2024.12.005_bib47","first-page":"126","article-title":"The hidden continuum of HIV-associated cardiomyopathy: a focussed review with case reports","volume":"18","author":"Robbertse","year":"2021","journal-title":"SA Heart J"},{"issue":"2","key":"10.1016\/j.hfc.2024.12.005_bib48","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/ccd.25466","article-title":"Safety and long-term outcomes after percutaneous coronary intervention in patients with human immunodeficiency virus","volume":"85","author":"Badr","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.hfc.2024.12.005_bib49","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1016\/j.jtcvs.2014.07.074","article-title":"Outcomes of patients with human immunodeficiency virus infection undergoing cardiovascular surgery in the United States","volume":"148","author":"Robich","year":"2014","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.005_bib50","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/ATVBAHA.120.315569","article-title":"Multihit interactions of antigens, immune responses, and comorbidities in cardiovascular disease pathogenesis: methods and potential mechanisms","volume":"41","author":"Feinstein","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1016\/j.hfc.2024.12.005_bib51","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"New Engl J Med"},{"issue":"26","key":"10.1016\/j.hfc.2024.12.005_bib52","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"New Engl J Med"},{"issue":"19","key":"10.1016\/j.hfc.2024.12.005_bib53","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"New Engl J Med"},{"key":"10.1016\/j.hfc.2024.12.005_bib54","article-title":"A\u00a0blood immunological signature of subclinical coronary artery atherosclerosis in people living with HIV-1 receiving antiretroviral therapy","author":"Wiche Salinas","year":"2023","journal-title":"bioRxiv"},{"issue":"6","key":"10.1016\/j.hfc.2024.12.005_bib55","doi-asserted-by":"crossref","first-page":"e2114923","DOI":"10.1001\/jamanetworkopen.2021.14923","article-title":"Assessment of coronary artery disease with computed tomography angiography and inflammatory and immune activation biomarkers among adults with HIV eligible for primary cardiovascular prevention","volume":"4","author":"Hoffmann","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.hfc.2024.12.005_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/v15030700","article-title":"Differential impact of IL-32 isoforms on the functions of coronary artery endothelial cells: a potential link with arterial stiffness and atherosclerosis","volume":"15","author":"Bunet","year":"2023","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.hfc.2024.12.005_bib57","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/QAD.0000000000002079","article-title":"GlycA, a novel inflammatory marker, is associated with subclinical coronary disease","volume":"33","author":"Tibuakuu","year":"2019","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.hfc.2024.12.005_bib58","first-page":"58","article-title":"Endothelial dysfunction in HIV-positive patients with acute coronary syndromes","volume":"31","author":"Vachiat","year":"2020","journal-title":"Cardiovasc J Afr"},{"issue":"15","key":"10.1016\/j.hfc.2024.12.005_bib59","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1097\/QAD.0000000000003048","article-title":"Plasma galectin-9 as a predictor of adverse non-AIDS events in persons with chronic HIV during suppressive antiretroviral therapy","volume":"35","author":"Premeaux","year":"2021","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.hfc.2024.12.005_bib60","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/infdis\/jiy524","article-title":"Gut microbiota in human immunodeficiency virus-infected individuals linked to coronary heart disease","volume":"219","author":"Kehrmann","year":"2019","journal-title":"J\u00a0Infect Dis"},{"issue":"10","key":"10.1016\/j.hfc.2024.12.005_bib61","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1161\/CIRCRESAHA.121.320090","article-title":"Human coronary plaque T cells are clonal and cross-react to virus and self","volume":"130","author":"Chowdhury","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2024.12.005_bib62","doi-asserted-by":"crossref","first-page":"103896","DOI":"10.1016\/j.ebiom.2022.103896","article-title":"Ageing with HIV: challenges and biomarkers","volume":"77","author":"Rod\u00e9s","year":"2022","journal-title":"EBioMedicine"},{"issue":"19","key":"10.1016\/j.hfc.2024.12.005_bib63","doi-asserted-by":"crossref","first-page":"22772","DOI":"10.18632\/aging.203625","article-title":"Immunological age prediction in HIV-infected, ART-treated individuals","volume":"13","author":"de Armas","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"10.1016\/j.hfc.2024.12.005_bib64","doi-asserted-by":"crossref","first-page":"e2070","DOI":"10.1093\/cid\/ciaa1034","article-title":"Telomere length, traditional risk factors, factors related to human immunodeficiency virus (HIV) and coronary artery disease events in Swiss persons living with HIV","volume":"73","author":"Engel","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.005_bib65","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12979-021-00245-w","article-title":"Metabolic phenotype of B cells from young and elderly HIV individuals","volume":"18","author":"Frasca","year":"2021","journal-title":"Immun Ageing"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.005_bib66","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1097\/QAI.0000000000002001","article-title":"PD-1+ and TIGIT+ CD4 T cells are associated with coronary artery calcium progression in HIV-infected treated adults","volume":"81","author":"Bowler","year":"2019","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.005_bib67","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/cid\/ciac758","article-title":"Polygenic risk scores for prediction of subclinical coronary artery disease in persons with human immunodeficiency virus (HIV): the Swiss HIV cohort study","volume":"76","author":"Schoepf","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.hfc.2024.12.005_bib68","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijcard.2023.04.058","article-title":"Polygenic risk scores point toward potential genetic mechanisms of type 2 myocardial infarction in people with HIV","volume":"383","author":"Lee","year":"2023","journal-title":"Int J Cardiol"},{"issue":"15","key":"10.1016\/j.hfc.2024.12.005_bib69","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1097\/QAD.0000000000002368","article-title":"MicroRNA biomarkers associated with type 1 myocardial infarction in HIV-positive individuals","volume":"33","author":"Yuan","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.hfc.2024.12.005_bib70","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.yjmcc.2021.07.004","article-title":"Clonal hematopoiesis of indeterminate potential (CHIP): linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease","volume":"161","author":"Marnell","year":"2021","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.hfc.2024.12.005_bib71","article-title":"Clonal hematopoiesis of indeterminate potential in Persons living with HIV","author":"Knudsen","year":"2023","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.hfc.2024.12.005_bib72","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/QAD.0000000000003280","article-title":"Clonal hematopoiesis in men living with HIV and association with subclinical atherosclerosis","volume":"36","author":"Wang","year":"2022","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.hfc.2024.12.005_bib73","doi-asserted-by":"crossref","first-page":"e0281701","DOI":"10.1371\/journal.pone.0281701","article-title":"An efficient approach to estimate the risk of coronary artery disease for people living with HIV using machine-learning-based retinal image analysis","volume":"18","author":"Lui","year":"2023","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.005_bib74","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1148\/radiol.2021203179","article-title":"Contribution of risk factors to the development of coronary atherosclerosis as confirmed via coronary CT angiography: a longitudinal radiomics-based study","volume":"299","author":"Kolossv\u00e1ry","year":"2021","journal-title":"Radiology"},{"issue":"43","key":"10.1016\/j.hfc.2024.12.005_bib75","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1093\/eurheartj\/ehz592","article-title":"A\u00a0novel machine learning-derived radiotranscriptomic signature of perivascular fat improves cardiac risk prediction using coronary CT angiography","volume":"40","author":"Oikonomou","year":"2019","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.hfc.2024.12.005_bib76","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/hiv.13124","article-title":"Prediction of future cardiovascular events by Framingham, SCORE and asCVD risk scores is less accurate in HIV-positive individuals from the HIV-HEART Study compared with the general population","volume":"22","author":"Schulz","year":"2021","journal-title":"HIV Med"},{"issue":"2","key":"10.1016\/j.hfc.2024.12.005_bib77","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/QAD.0000000000003093","article-title":"Coronary artery plaque progression and cardiovascular risk scores in men with and without HIV-infection","volume":"36","author":"Shaikh","year":"2022","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.hfc.2024.12.005_bib78","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/2047487315579291","article-title":"An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: the Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study","volume":"23","author":"Friis-M\u00f8ller","year":"2016","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2024.12.005_bib79","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11904-021-00567-w","article-title":"Assessing cardiovascular risk in people living with HIV: current tools and limitations","volume":"18","author":"Achhra","year":"2021","journal-title":"Curr HIV AIDS Rep"},{"issue":"6","key":"10.1016\/j.hfc.2024.12.005_bib80","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/QAD.0000000000002151","article-title":"Associations between lipids and subclinical coronary atherosclerosis","volume":"33","author":"Whelton","year":"2019","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.hfc.2024.12.005_bib81","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/ehjqcco\/qcaa088","article-title":"Longitudinal management and outcomes of acute coronary syndrome in persons living with HIV infection","volume":"7","author":"Parks","year":"2021","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.005_bib82","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12875-021-01563-0","article-title":"Factors affecting statin uptake among people living with HIV: primary care provider perspectives","volume":"22","author":"Ober","year":"2021","journal-title":"BMC Fam Pract"},{"issue":"2","key":"10.1016\/j.hfc.2024.12.005_bib83","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pcad.2020.02.012","article-title":"Reducing cardiovascular risk among people living with HIV: rationale and design of the INcreasing Statin Prescribing in HIV Behavioral Economics REsearch (INSPIRE) randomized controlled trial","volume":"63","author":"Takada","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"issue":"8","key":"10.1016\/j.hfc.2024.12.005_bib84","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2304146","article-title":"Pitavastatin to prevent cardiovascular disease in HIV infection","volume":"389","author":"Grinspoon","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hfc.2024.12.005_bib85","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jcct.2019.08.011","article-title":"Individual coronary plaque changes on serial CT angiography: within-patient heterogeneity, natural history, and statin effects in HIV","volume":"14","author":"Foldyna","year":"2020","journal-title":"J\u00a0Cardiovasc Comput Tomogr"},{"issue":"5","key":"10.1016\/j.hfc.2024.12.005_bib86","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/aid.2020.0127","article-title":"Effect of statin use on inflammation and immune activation biomarkers in HIV-infected persons on effective antiretroviral therapy","volume":"37","author":"Hussain","year":"2021","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"11","key":"10.1016\/j.hfc.2024.12.005_bib88","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1093\/cid\/ciy781","article-title":"Safety and impact of low-dose methotrexate on endothelial function and inflammation in individuals with treated human immunodeficiency virus: AIDS clinical trials group study A5314","volume":"68","author":"Hsue","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.hfc.2024.12.005_bib89","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/QAD.0000000000002845","article-title":"A\u00a0randomized, placebo-controlled, double-blinded clinical trial of colchicine to improve vascular health in people living with HIV","volume":"35","author":"Hays","year":"2021","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.hfc.2024.12.005_bib90","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1097\/QAD.0000000000003656","article-title":"An open label randomized controlled trial of atorvastatin versus aspirin in elite controllers and antiretroviral-treated people with HIV","volume":"37","author":"Mystakelis","year":"2023","journal-title":"AIDS"},{"key":"10.1016\/j.hfc.2024.12.005_bib91","article-title":"Mineralocorticoid receptor antagonism by eplerenone and arterial inflammation in HIV: the MIRABELLA HIV study","author":"Srinivasa","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"8","key":"10.1016\/j.hfc.2024.12.005_bib92","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/cid\/ciad310","article-title":"Randomized placebo-controlled trial to evaluate effects of eplerenone on myocardial perfusion and function among persons with human immunodeficiency virus (HIV)-Results from the MIRACLE HIV study","volume":"77","author":"Srinivasa","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"14","key":"10.1016\/j.hfc.2024.12.005_bib93","doi-asserted-by":"crossref","first-page":"e016263","DOI":"10.1161\/JAHA.120.016263","article-title":"Evolocumab, a PCSK9-monoclonal antibody, rapidly reverses coronary artery endothelial dysfunction in people living with HIV and people with dyslipidemia","volume":"9","author":"Leucker","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"22","key":"10.1016\/j.hfc.2024.12.005_bib94","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/j.jacc.2018.09.038","article-title":"IL-1\u03b2 inhibition reduces atherosclerotic inflammation in HIV infection","volume":"72","author":"Hsue","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.hfc.2024.12.005_bib95","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker","year":"2018","journal-title":"New Engl J Med"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713624001016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713624001016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T03:05:32Z","timestamp":1750302332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713624001016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1551713624001016"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2024.12.005","relation":{},"ISSN":["1551-7136"],"issn-type":[{"type":"print","value":"1551-7136"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune Dysregulation in Ischemic Heart Disease Among Individuals with Human Immunodeficiency Virus","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2024.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}